Herbridge, 18 Aug. 2011_Mature a product as it is, baicalin also sees higher prices.
With wild scutellaria in short, the plant is also cultivated in Shandong, Shanxi and Inner Mongolia of China. Most manufacturers buy cultivated scutellaria from farmers for the extracts' production. The inflation resulted in slightly higher prices last year. However, the short supply of scutellaria cause the baicalin market to fluctuate sharply this year in China. Most manufacturers primarily offer common baicalin for old customers. Considering the stable demand, manufacturers don't expand production capacity. Some manufacturers have no baicalin in stock, but they won't carry out production until late 2011when the new crop arrives in China.
According to herbridge.com, baicalin prices still have upward tendency. But it needs time for customers to accept higher prices, which in turn inhibit prices' increase. While the prices for 90% baicalin at injection level are around 350RMB/kg now, the prices for 85% baicalin at oral level are around 280RMB/kg in China.
Copyright: www.herbridge.com
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
